{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:22:16Z","timestamp":1782184936836,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bmc.2023.117377","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T16:50:58Z","timestamp":1686847858000},"page":"117377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Design, synthesis and evaluation the bioactivities of novel 1,3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents"],"prefix":"10.1016","volume":"90","author":[{"given":"Van-Hai","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Kieu","family":"Trang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong Cao","family":"Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thien Bao","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Hoang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Hue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Quoc","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Xuan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Thi Kim","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong-Thao","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117377_b0005","first-page":"101","article-title":"The immune system in cancer prevention, development and therapy","volume":"16:","author":"Candeias","year":"2016","journal-title":"Anti-Cancer Agents Medicinal Chem (Formerly Curr Medicinal Chem-Anti-Cancer Agents)"},{"key":"10.1016\/j.bmc.2023.117377_b0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fimmu.2016.00246","article-title":"Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis","volume":"7","author":"Lovelace","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2023.117377_b0015","series-title":"Targeting the broadly pathogenic kynurenine pathway","author":"Mittal","year":"2015"},{"key":"10.1016\/j.bmc.2023.117377_b0020","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1021\/acs.jmedchem.5b00461","article-title":"Challenges and opportunities in the discovery of new therapeutics targeting the kynurenine pathway","volume":"58","author":"Dounay","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117377_b0025","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","article-title":"Prognostic value of indoleamine 2, 3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells","volume":"12","author":"Brandacher","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117377_b0030","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-11-1331","article-title":"Indoleamine 2, 3-dioxygenase expression in human cancers: clinical and immunologic perspectives","volume":"17","author":"Godin-Ethier","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117377_b0035","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2, 3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2023.117377_b0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.18632\/aging.101756","article-title":"Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysis","volume":"11","author":"Jia","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bmc.2023.117377_b0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/coa.13794","article-title":"The immunotherapeutic role of indoleamine 2, 3-dioxygenase in head and neck squamous cell carcinoma: A systematic review","volume":"46","author":"Lin","year":"2021","journal-title":"Clin Otolaryngol"},{"issue":"13_Supplement","key":"10.1016\/j.bmc.2023.117377_b0050","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2018-5481","article-title":"Targeting the kynurenine pathway as a novel metabolic treatment for head and neck cancer","volume":"78","author":"Subramanian","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2023.117377_b0055","doi-asserted-by":"crossref","first-page":"17690","DOI":"10.1021\/acs.jmedchem.1c01665","article-title":"Structure and plasticity of indoleamine 2, 3-dioxygenase 1 (IDO1)","volume":"64","author":"R\u00f6hrig","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117377_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113071","article-title":"Diverse chemical space of indoleamine-2, 3-dioxygenase 1 (Ido1) inhibitors","volume":"211","author":"Singh","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117377_b0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejmech.2017.11.088","article-title":"Recent discovery of indoleamine-2, 3-dioxygenase 1 inhibitors targeting cancer immunotherapy","volume":"143","author":"Weng","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117377_b0070","doi-asserted-by":"crossref","DOI":"10.4161\/onci.23428","article-title":"Indoleamine 2, 3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer","volume":"2","author":"Creelan","year":"2013","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.bmc.2023.117377_b0075","doi-asserted-by":"crossref","first-page":"21319","DOI":"10.1038\/srep21319","article-title":"Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117377_b0080","unstructured":"Tran P.-T., Hoang V.-H. Indoleamine 2,3-Dioxygenase 1 Inhibitors: Discovery, Development, and Promise in Cancer Immunotherapy. In: Silva-J\u00fanior EFd, editor. Advances in Medicinal Chemistry Research. New Developments in Medical Research: Nova Science Publishers, Inc.; 2019. p. 247-81."},{"key":"10.1016\/j.bmc.2023.117377_b0085","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1002\/slct.201700906","article-title":"Identification of Substituted 1H-Indazoles as Potent Inhibitors for Immunosuppressive Enzyme Indoleamine 2, 3-Dioxygenase 1","volume":"2","author":"Pradhan","year":"2017","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2023.117377_b0090","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.bmc.2016.10.003","article-title":"Discovery and preliminary structure\u2013activity relationship of 1H-indazoles with promising indoleamine-2, 3-dioxygenase 1 (IDO1) inhibition properties","volume":"24","author":"Qian","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117377_b0095","doi-asserted-by":"crossref","first-page":"45199","DOI":"10.1039\/D0RA09112J","article-title":"Design, synthesis and bioevaluation of novel 6-substituted aminoindazole derivatives as anticancer agents","volume":"10","author":"Hoang","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117377_b0100","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1021\/ml500247w","article-title":"Crystal structures and structure\u2013activity relationships of imidazothiazole derivatives as IDO1 inhibitors","volume":"5","author":"Tojo","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117377_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01725-8","article-title":"Structural insights into substrate and inhibitor binding sites in human indoleamine 2, 3-dioxygenase 1","volume":"8","author":"Lewis-Ballester","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2023.117377_b0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/acs.jmedchem.5b01390","article-title":"Important hydrogen bond networks in indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitor design revealed by crystal structures of imidazoleisoindole derivatives with IDO1","volume":"59","author":"Peng","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117377_b0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13543776.2018.1441290","article-title":"A patent review of IDO1 inhibitors for cancer","volume":"28","author":"Cheong","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2023.117377_b0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-cancerbio-030419-033635","article-title":"Is there a clinical future for IDO1 inhibitors after the failure of epacadostat in melanoma?","volume":"4","author":"Van den Eynde","year":"2020","journal-title":"Ann Rev Cancer Biol"},{"key":"10.1016\/j.bmc.2023.117377_b0125","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.3892\/ol.2016.4333","article-title":"Prognostic significance of claudin-1 and cyclin B1 protein expression in patients with hypopharyngeal squamous cell carcinoma","volume":"11","author":"Li","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmc.2023.117377_b0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623002250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623002250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:26:09Z","timestamp":1760837169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623002250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":26,"alternative-id":["S0968089623002250"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117377","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation the bioactivities of novel 1,3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117377"}}